3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Leukemia, Myeloid, Acute
7
Myelodysplastic Syndromes
6
Hodgkin Disease
5
Lymphoma, Non-Hodgkin
4
Lymphoma, Mantle-Cell
4
Lymphoma, Large B-Cell, Diffuse
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Leukemia
4
Myelodysplastic-Myeloproliferative Diseases
3
Multiple Myeloma
3
Lymphoma, Follicular
3
Lymphoma, B-Cell, Marginal Zone
3
Leukemia, Prolymphocytic
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Burkitt Lymphoma
3
Anemia, Refractory, with Excess of Blasts
3
Waldenstrom Macroglobulinemia
2
Primary Myelofibrosis
2
Myeloproliferative Disorders
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoma
2
Leukemia, Myelomonocytic, Chronic
2
Graft vs Host Disease
2
Congenital Abnormalities
2
Blast Crisis
2
Thrombocythemia, Essential
1
Sezary Syndrome
1
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
trastuzumab deruxtecan
1
sacituzumab govitecan
1
Methylprednisolone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Drug-Related Side Effects and Adverse Reactions
×
Cyclosporine
×
30 days
×
Clear all
No trials found.